Drawing for MEDIPLUS

USPTO serial 79100628

MEDIPLUS

Reviewed by CopyMark Law Group

Reg. 4177558Status 706Registered
Filing date
Status date
Registration date
Jul 24, 2012
Examiner
JUN, WON KYUNG WENDY
Law office
GENERIC WEB UPDATE

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Need help with MEDIPLUS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Austin Padgett, Esq.

Austin Padgett, Esq. Troutman Sanders LLP600 Peachtree Street NE Suite 3000Atlanta, GA 30308UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Hydrocolloid adhesive wound dressing, adhesive dressings for medical purposes; polyurethane dressings for medical purposes; polyurethane dressings for use as medical dressings, polyurethane foam bandages for dressings, alginate wound dressings; [surgical dressings incorporating collagen, gauze, skin care creams for medical use-casts for orthopaedic purposes; ] [adhesive for bandages for skin wounds;] sterilized medical dressing for use in or after intravenous administration; non-adherent medical dressing; post-operative surgical dressings; [medicated pre-moistened wipes for surgical use; transparent medical dressing; ] first aid bandages for dressings, dressings for skin wounds,-dressing with hydrogel for skin woundsACTIVE—
010Supportive bandages, suspensory bandages, elastic bandages[; medical apparatus for managing wound care, namely, devices for measuring wounds, wound drainage apparatus, wound suction apparatus; surgical drapes, namely, self-adhesive drapes for surgical use; surgical drapes, namely, surgical drape sheets for use in locating incision field; compression bandages; plaster casts for orthopedic purposes]ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 11, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Oct 23, 2023INNPPARTIAL INVALIDATION PROCESSED BY THE IB—
Sep 2, 2023INPSPARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Sep 2, 2023INPCINVALIDATION PROCESSED—
Aug 4, 2023INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Dec 5, 2022NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Dec 4, 202271AGREGISTERED-SEC.71 ACCEPTED—
Nov 22, 2022APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jun 13, 2022ES71TEAS SECTION 71 RECEIVED—
May 27, 2022NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jul 24, 2021REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED—
Jun 17, 2021RNWLINTERNATIONAL REGISTRATION RENEWED—
Aug 25, 2020INNPPARTIAL INVALIDATION PROCESSED BY THE IB—
Jul 10, 2020INPSPARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Jul 10, 2020INPCINVALIDATION PROCESSED—
Jun 23, 2020INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Oct 23, 2019NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Oct 23, 201971AGREGISTERED-SEC.71 ACCEPTED—
Oct 11, 2019ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Sep 6, 2019INNAINVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE—
Aug 14, 2019INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Aug 1, 2019APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jul 19, 2019EROPTEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED—
Jan 23, 2019PR71POST REGISTRATION ACTION MAILED - SEC.71—
Oct 20, 2018APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Sep 24, 2018EROPTEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED—
Mar 24, 2018PR71POST REGISTRATION ACTION MAILED - SEC.71—
Mar 9, 2018APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Mar 2, 2018ES71TEAS SECTION 71 RECEIVED—
Aug 26, 2016NREPNEW REPRESENTATIVE AT IB RECEIVED—
Nov 18, 2012FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Oct 26, 2012FICSFINAL DISPOSITION NOTICE SENT TO IB—
Oct 26, 2012FIMPFINAL DISPOSITION PROCESSED—
Oct 24, 2012FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jul 24, 2012R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 8, 2012PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 18, 2012NPUBNOTICE OF PUBLICATION—
Mar 31, 2012PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Mar 28, 2012CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 28, 2012CNEAEXAMINERS AMENDMENT MAILED—
Mar 28, 2012XAECEXAMINER'S AMENDMENT ENTERED—
Mar 28, 2012CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 26, 2012ACECAMENDMENT FROM APPLICANT ENTERED—
Mar 26, 2012CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 13, 2012ALIEASSIGNED TO LIE—
Feb 23, 2012MAILPAPER RECEIVED—
Oct 9, 2011RFNTREFUSAL PROCESSED BY IB—
Sep 21, 2011RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Sep 21, 2011RFRRREFUSAL PROCESSED BY MPU—
Sep 21, 2011RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Sep 20, 2011CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 19, 2011DOCKASSIGNED TO EXAMINER—
Aug 23, 2011MAFRAPPLICATION FILING RECEIPT MAILED—
Aug 19, 2011NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 18, 2011REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance